97 related articles for article (PubMed ID: 8708409)
1. Predominance of codon 215 mutation in reverse transcriptase-coding region of 3'-azido-3'-deoxythymidine (AZT)-resistant HIV-1 isolates after long-term AZT therapy.
Kondo M
Kansenshogaku Zasshi; 1995 Nov; 69(11):1278-85. PubMed ID: 8708409
[TBL] [Abstract][Full Text] [Related]
2. [Reverse transcriptase gene analysis of HIV-1 mutants cultured in the presence of AZT].
Kondo M; Saito T; Ito A; Oka S; Hamamoto K; Imai M
Kansenshogaku Zasshi; 1993 Oct; 67(10):992-7. PubMed ID: 7504715
[TBL] [Abstract][Full Text] [Related]
3. Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT).
Larder BA; Kemp SD
Science; 1989 Dec; 246(4934):1155-8. PubMed ID: 2479983
[TBL] [Abstract][Full Text] [Related]
4. [Mutations of HIV-1 RT gene isolated from patients treated with AZT].
Kondo M; Saito T; Ito A; Oka S; Takata N; Imai M
Kansenshogaku Zasshi; 1993 Mar; 67(3):185-9. PubMed ID: 7683706
[TBL] [Abstract][Full Text] [Related]
5. Reverse transcriptase sequence of paired isolates of cerebrospinal fluid and blood from patients infected with human immunodeficiency virus type 1 during zidovudine treatment.
Di Stefano M; Sabri F; Leitner T; Svennerholm B; Hagberg L; Norkrans G; Chiodi F
J Clin Microbiol; 1995 Feb; 33(2):352-5. PubMed ID: 7536214
[TBL] [Abstract][Full Text] [Related]
6. Rapid in vitro selection of human immunodeficiency virus type 1 resistant to 3'-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase.
Tisdale M; Kemp SD; Parry NR; Larder BA
Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5653-6. PubMed ID: 7685907
[TBL] [Abstract][Full Text] [Related]
7. pol mutations conferring zidovudine and didanosine resistance with different effects in vitro yield multiply resistant human immunodeficiency virus type 1 isolates in vivo.
Eron JJ; Chow YK; Caliendo AM; Videler J; Devore KM; Cooley TP; Liebman HA; Kaplan JC; Hirsch MS; D'Aquila RT
Antimicrob Agents Chemother; 1993 Jul; 37(7):1480-7. PubMed ID: 7689822
[TBL] [Abstract][Full Text] [Related]
8. An in vivo mutation from leucine to tryptophan at position 210 in human immunodeficiency virus type 1 reverse transcriptase contributes to high-level resistance to 3'-azido-3'-deoxythymidine.
Hooker DJ; Tachedjian G; Solomon AE; Gurusinghe AD; Land S; Birch C; Anderson JL; Roy BM; Arnold E; Deacon NJ
J Virol; 1996 Nov; 70(11):8010-8. PubMed ID: 8892925
[TBL] [Abstract][Full Text] [Related]
9. Mechanistic basis of zidovudine hypersusceptibility and lamivudine resistance conferred by the deletion of codon 69 in the HIV-1 reverse transcriptase coding region.
Kisic M; Mendieta J; Puertas MC; Parera M; Martínez MA; Martinez-Picado J; Menéndez-Arias L
J Mol Biol; 2008 Oct; 382(2):327-41. PubMed ID: 18662701
[TBL] [Abstract][Full Text] [Related]
10. Reverse transcriptase mutations in sequential HIV-1 isolates in a patient with AIDS.
Gurusinghe AD; Land SA; Birch C; McGavin C; Hooker DJ; Tachedjian G; Doherty R; Deacon NJ
J Med Virol; 1995 Jul; 46(3):238-43. PubMed ID: 7561796
[TBL] [Abstract][Full Text] [Related]
11. Characterization of HIV isolates arising after prolonged zidovudine therapy.
Mayers DL; McCutchan FE; Sanders-Buell EE; Merritt LI; Dilworth S; Fowler AK; Marks CA; Ruiz NM; Richman DD; Roberts CR
J Acquir Immune Defic Syndr (1988); 1992; 5(8):749-59. PubMed ID: 1381438
[TBL] [Abstract][Full Text] [Related]
12. Significance of amino acid variation at human immunodeficiency virus type 1 reverse transcriptase residue 210 for zidovudine susceptibility.
Harrigan PR; Kinghorn I; Bloor S; Kemp SD; Nájera I; Kohli A; Larder BA
J Virol; 1996 Sep; 70(9):5930-4. PubMed ID: 8709214
[TBL] [Abstract][Full Text] [Related]
13. Effects of the Delta67 complex of mutations in human immunodeficiency virus type 1 reverse transcriptase on nucleoside analog excision.
Boyer PL; Imamichi T; Sarafianos SG; Arnold E; Hughes SH
J Virol; 2004 Sep; 78(18):9987-97. PubMed ID: 15331732
[TBL] [Abstract][Full Text] [Related]
14. Sequence analysis of reverse transcriptase genes of zidovudine (AZT)-resistant and -sensitive human immunodeficiency virus type 1 strains.
Sheehy N; Desselberger U
J Gen Virol; 1993 Feb; 74 ( Pt 2)():223-8. PubMed ID: 7679140
[TBL] [Abstract][Full Text] [Related]
15. Fifth mutation in human immunodeficiency virus type 1 reverse transcriptase contributes to the development of high-level resistance to zidovudine.
Kellam P; Boucher CA; Larder BA
Proc Natl Acad Sci U S A; 1992 Mar; 89(5):1934-8. PubMed ID: 1371886
[TBL] [Abstract][Full Text] [Related]
16. Resistance to ddI and sensitivity to AZT induced by a mutation in HIV-1 reverse transcriptase.
St Clair MH; Martin JL; Tudor-Williams G; Bach MC; Vavro CL; King DM; Kellam P; Kemp SD; Larder BA
Science; 1991 Sep; 253(5027):1557-9. PubMed ID: 1716788
[TBL] [Abstract][Full Text] [Related]
17. Mutagenic study of codons 74 and 215 of the human immunodeficiency virus type 1 reverse transcriptase, which are significant in nucleoside analog resistance.
Lacey SF; Larder BA
J Virol; 1994 May; 68(5):3421-4. PubMed ID: 7512165
[TBL] [Abstract][Full Text] [Related]
18. Quantitation of zidovudine-resistant human immunodeficiency virus type 1 in the blood of treated and untreated patients.
Mohri H; Singh MK; Ching WT; Ho DD
Proc Natl Acad Sci U S A; 1993 Jan; 90(1):25-9. PubMed ID: 7678340
[TBL] [Abstract][Full Text] [Related]
19. Role of a dipeptide insertion between codons 69 and 70 of HIV-1 reverse transcriptase in the mechanism of AZT resistance.
Mas A; Parera M; Briones C; Soriano V; Martínez MA; Domingo E; Menéndez-Arias L
EMBO J; 2000 Nov; 19(21):5752-61. PubMed ID: 11060026
[TBL] [Abstract][Full Text] [Related]
20. In vivo comparison of zidovudine resistance mutations in blood and CSF of HIV-1-infected patients.
Wildemann B; Haas J; Ehrhart K; Wagner H; Lynen N; Storch-Hagenlocher B
Neurology; 1993 Dec; 43(12):2659-63. PubMed ID: 7504798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
